Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Fair Value 2026

SHPH · Drug Manufacturers - Specialty & Generic ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.6 /10

32 fundamental signals · 0 models active

Value Trap Risk

DANGER (68/100)

Quick Summary — As of 2026-08-28, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trades at $3.54. QOC: 3.6/10. Value Trap Risk: 68/100 (DANGER). 0/13 models active.

Key Facts

Ticker
SHPH
Price
$3.54
Quality Score
3.6/10
Value Trap Risk
68/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 68 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give SHPH?

0 Intrinsic Value Models vs. Current Price ($3.54)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Shuttle Pharmaceuticals Holdings, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About SHPH?

0 of 13 models are currently active for SHPH. See which stocks rank higher →

How Does SHPH Rank in Drug Manufacturers - Specialty & Generic?

Among 112 Drug Manufacturers - Specialty & Generic stocks, SHPH ranks #102 by Quality of Company score. CirclFi's QOC score of 3.6/10 evaluates 32 fundamental signals. A score of 3.6 signals below-average fundamentals.

See all Most Undervalued Drug Manufacturers - Specialty & Generic Stocks →

Within the Drug Manufacturers - Specialty & Generic space, Shuttle Pharmaceuticals Holdings, Inc. competes in an environment where pipeline depth and stage distribution often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is SHPH a Value Trap?

CirclFi's Value Trap algorithm assigns SHPH a score of 68/100 (DANGER). This is a high-risk signal. Deteriorating fundamentals suggest the discount may be justified. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Shuttle Pharmaceuticals Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Shuttle Pharmaceuticals Holdings, Inc. is rated at 3.6/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses. Notably, value trap risk is elevated.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SHPH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Shuttle Pharmaceuticals Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Drug Manufacturers - Specialty & Generic Stocks Should You Also Analyze?

11 related Drug Manufacturers - Specialty & Generic stocks with 13-model coverage

KAYSKaya Holdings, Inc.QOC 3.9NIKANIKA PHARMACEUTICALS INC.QOC 3.5RDHLRedHill Biopharma Ltd.QOC 4.1GREHGreen Rain Energy Holdings Inc.QOC 3.3PTPIPetros Pharmaceuticals, Inc.QOC 4.1CTTHCTT Pharmaceutical Holdings, Inc.QOC 3.3KNSAKiniksa Pharmaceuticals International, plcQOC 8.1TXMDTherapeuticsMD, Inc.QOC 6.2SKYISky Century Investment, Inc.QOC 5.2UTHRUnited Therapeutics CorporationQOC 9.6AMPHAmphastar Pharmaceuticals, Inc.QOC 9.4

Read investment analysis: KAYS · NIKA · RDHL · GREH · PTPI · CTTH · KNSA · TXMD · SKYI · UTHR · AMPH

Which Other Stocks Have a Similar Quality Score to SHPH?

7 companies across all industries closest to SHPH’s Quality of Company score of 3.6/10.

YSSYork Space Systems, Inc.QOC 3.6FYNNFyntechnical Innovations Inc.QOC 3.6XERIXeriant, Inc.QOC 3.7EEGIEline Entertainment Group, Inc.QOC 3.6USBCUSBC, Inc.QOC 3.7AVATAvalanche Treasury CorporationQOC 3.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: YSS · FYNN · XERI · EEGI · USBC · AVAT · NVDA

Where Does SHPH Sit in CirclFi's Drug Manufacturers - Specialty & Generic Rankings?

SHPH is ranked against every other Drug Manufacturers - Specialty & Generic stock CirclFi covers in each of these screens.

See all Drug Manufacturers - Specialty & Generic stocks ranked →

What Else Do Investors Ask About Shuttle Pharmaceuticals Holdings, Inc.’s Valuation?

What is Shuttle Pharmaceuticals Holdings, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Shuttle Pharmaceuticals Holdings, Inc. (SHPH). The Quality of Company score is 3.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SHPH overvalued or undervalued right now?

At $3.54, 0 of 0 active models suggest SHPH may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Shuttle Pharmaceuticals Holdings, Inc.'s business model in Drug Manufacturers - Specialty & Generic.

What does a Quality of Company score of 3.6 mean for SHPH?

Shuttle Pharmaceuticals Holdings, Inc.'s QOC of 3.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on SHPH?

CirclFi analyzes SHPH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is SHPH a value trap in 2026?

Shuttle Pharmaceuticals Holdings, Inc.'s Value Trap score is 68/100 (DANGER). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Shuttle Pharmaceuticals Holdings, Inc. (SHPH) a Quality of Company score of 3.6/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SHPH/ · Methodology
Primary sources for this SHPH valuation

Market data for SHPH as of ; valuations recomputed .